MHC LLP Advises Surmodics on Acquisition of Vetex Medical
08 July 2021
We are pleased to have acted for Surmodics Inc. on the acquisition of Vetex Medical Limited.
Surmodics, a Nasdaq listed medtech company based in Minnesota, is a leading provider of medical device and in vitro diagnostic technologies to the health care industry.
The deal for Galway-based Vetex expands Surmodics’ thrombectomy portfolio with a second US FDA approved device, the ReVene Thrombectomy Catheter. This device developed by Vetex is specifically designed to remove large, mixed-morphology blood clots commonly found with venous thromboembolism.